Legal status by country
Is Everolimus legal?
Written by Aaron CuhaReviewed Sep 2026
How Everolimus is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Approved | Approved | Approved |
| Classification | FDA-approved, prescription only | Licensed, prescription only (MHRA) | TGA-registered, prescription only | Health Canada approved, prescription only |
| Note | Approved for oncology indications and transplant rejection prophylaxis. Immune-ageing and longevity uses are investigational and off-label. | None recorded | None recorded | None recorded |
US FDA status: FDA-approved as Afinitor for several cancers and as Zortress for prophylaxis of organ rejection. Not approved for any ageing or immune-ageing indication.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.